IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$297M
AUM Growth
-$31.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
70
New
Increased
Reduced
Closed

Top Buys

1
+$11M
2
+$8.45M
3
+$8.21M
4
BIIB icon
Biogen
BIIB
+$7.81M
5
GILD icon
Gilead Sciences
GILD
+$6.85M

Top Sells

1
+$14.3M
2
+$11.8M
3
+$9.48M
4
HRMY icon
Harmony Biosciences
HRMY
+$8.89M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$8.55M

Sector Composition

1 Healthcare 99.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
1
Amgen
AMGN
$208B
$21.3M 7.17%
79,246
-38,000
INCY icon
2
Incyte
INCY
$19.9B
$20.7M 6.97%
358,454
GILD icon
3
Gilead Sciences
GILD
$186B
$17.5M 5.9%
233,584
+89,000
ITCI
4
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$16.5M 5.57%
317,856
+141,000
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.5B
$13.6M 4.58%
153,656
+95,000
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$3.17B
$11.8M 3.96%
426,500
-97,000
VERA icon
7
Vera Therapeutics
VERA
$2.87B
$10.4M 3.5%
758,355
-216,872
BIIB icon
8
Biogen
BIIB
$27.6B
$10.3M 3.48%
40,200
+29,200
HRMY icon
9
Harmony Biosciences
HRMY
$1.66B
$10.3M 3.47%
314,500
-256,000
MRTX
10
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$9.4M 3.17%
216,000
-44,000
RARE icon
11
Ultragenyx Pharmaceutical
RARE
$2.22B
$8.91M 3%
250,052
+170,000
QURE icon
12
uniQure
QURE
$654M
$8.33M 2.81%
1,241,500
+1,226,000
AUPH icon
13
Aurinia Pharmaceuticals
AUPH
$1.87B
$8.07M 2.72%
1,040,530
+467,000
UTHR icon
14
United Therapeutics
UTHR
$22.1B
$7.66M 2.58%
33,959
-18,800
VRTX icon
15
Vertex Pharmaceuticals
VRTX
$123B
$7.3M 2.46%
21,000
REGN icon
16
Regeneron Pharmaceuticals
REGN
$83.6B
$7.28M 2.45%
8,847
-18,153
ILMN icon
17
Illumina
ILMN
$20.3B
$6.93M 2.34%
51,914
ALNY icon
18
Alnylam Pharmaceuticals
ALNY
$43.1B
$6.52M 2.2%
36,800
-44,800
AMLX icon
19
Amylyx Pharmaceuticals
AMLX
$1.68B
$5.4M 1.82%
295,000
+270,000
KRYS icon
20
Krystal Biotech
KRYS
$7.57B
$5.34M 1.8%
46,092
+147
KRTX
21
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$5.16M 1.74%
30,500
+4,800
AXSM icon
22
Axsome Therapeutics
AXSM
$8.51B
$4.07M 1.37%
58,300
ERAS icon
23
Erasca
ERAS
$4.5B
$3.79M 1.28%
1,926,000
+500,000
ACAD icon
24
Acadia Pharmaceuticals
ACAD
$3.86B
$3.74M 1.26%
179,702
+28,702
RVNC
25
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.31M 1.11%
288,726
1
2 3